Alembic Pharmaceuticals Limited (APLLTD) secures USFDA tentative approval for Larotrectinib Capsules, marking a significant milestone.
Glenmark Pharmaceuticals Limited (GLENMARK) launches Winlevi® cream in key European markets, marking first NCE launch and strengthening dermatology portfolio.
Panacea Biotec Limited (NSE: PANACEABIO) launches DE NSTAR project to advance dengue vaccine DengiA/1 licensure in Sub-Saharan Africa.
Viyash Scientific Limited (VIYASH) acquires Italy's BioForLife, boosting its European companion animal health market presence.
Lupin Limited partners with LABORATORIOS ERN S.A. to launch Luforbec® in Spain, expanding respiratory care access.
Alembic Pharmaceuticals Limited (NSE: APLLTD) secures USFDA final approval for Haloperidol Tablets, expanding its generic drug portfolio.
Aurobindo Pharma Limited (AUROPHARMA) secures final approval from US FDA for Tofacitinib Tablets, targeting a US$494 million market.
Wockhardt Limited (WOCKPHARMA) showcases innovation, performance, and growth at its June 2026 investor conference.
Suven Life Sciences Limited (SUVEN) announces positive DSMB safety review and interim analysis from ongoing global Phase 3 study of Masupirdine in Alzheimer'.
Aurobindo Pharma Limited (AUROPHARMA) inaugurates TheraNym, a pioneering biologics contract manufacturing facility in Hyderabad, India, with MSD as its ancho.